This may be related to PI3K inhibitor LY294002 increasing the expression level of ZO-1 and Claudin-5, effectively improving BBB permeability after brain injury in mice with anti-NMDAR encephalitis and thus reducing the damage of anti-NMDAR antibody to NMDAR. Here, CLDN5 is linked to encephalitis.